Wernicke's Encephalopathy (WE) is a serious neurological disorder resu
lting from thiamine deficiency, encountered in chronic alcoholics and
in patients with grossly impaired nutritional status. Neuropathologic
studies as well as Magnetic Resonance Imaging reveal selective diencep
halic and brainstem lesions in patients with WE. The last decade has w
itnessed major advances in the understanding of pathophysiologic mecha
nisms linking thiamine deficiency to the selective brain lesions chara
cteristic of WE. Activities of the thiamine-dependent enzyme alpha-ket
oglutarate dehydrogenase, a rate-limiting tricarboxylic acid cycle enz
yme are significantly reduced in autopsied brain tissue from patients
with WE and from rats treated with the central thiamine antagonist, py
rithiamine. In the animal studies, evidence suggests that such enzyme
deficits result in focal lactic acidosis, cerebral energy impairment a
nd depolarization resulting from increased release of glutamate in vul
nerable brain structures. It has been proposed that this depolarizatio
n may result in N-Methyl-D-Aspartate receptor-mediated excitotoxicity
as well as increased expression of immediate early genes such as c-fos
and c-jun resulting in apoptotic cell death. Other mechanisms involve
d in thiamine deficiency-induced cell loss may involve free radicals a
nd alterations of the blood-brain barrier. Additional studies are stil
l required to identify the site of the initial cellular insult and to
explain the predilection of diencephalic and brainstem structures due
to thiamine deficiency.